Wiebke K Peitsch

7PUBLICATIONS
25CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsRadiation and matterEconometric and statistical methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 07, 2025
Switching PD-1 to BRAF + MEK inhibition improves recurrence-free survival in patients receiving a second course of adjuvant melanoma therapy.

Katharina Schumann, Kai Christian Klespe, Cornelia Mauch

|Nov 26, 2022
Real-world outcomes using PD-1 antibodies and BRAF + MEK inhibitors for adjuvant melanoma treatment from 39 skin cancer centers in Germany, Austria and Switzerland.

Katharina Schumann, Cornelia Mauch, Kai-Christian Klespe

|Aug 25, 2022
Unique and common TCR repertoire features of Ni2+ -, Co2+ -, and Pd2+ -specific human CD154 + CD4+ T cells.

Franziska Riedel, Marina Aparicio-Soto, Caterina Curato

|Jan 04, 2018
Biologicals and small molecules in psoriasis: A systematic review of economic evaluations.

Christian Kromer, Daniel Celis, Diana Sonntag

Pageof 2

Frequent Collaborators

2 joint publications

Reinhard Dummer

2 joint publications

Alexander Thiem

1 joint publications

Franziska Riedel

1 joint publications

Marina Aparicio-Soto